Molina Healthcare, Inc. (MOH) AI Stock Analysis

Molina Healthcare, Inc., based in Long Beach, California, specializes in delivering managed healthcare services to low-income families and individuals across the United States. Established in 1980, the company operates primarily through four distinct segments: Medicaid, Medicare, Marketplace, and Other. Its comprehensive service offerings cater to members eligible for Medicaid and Medicare, as well as those enrolled in state insurance marketplaces and other government-sponsored healthcare programs. As of December 31, 2021, Molina Healthcare served approximately 5.2 million members. The company employs 19,000 people and aims to promote health equity for underserved populations.

Annual revenue increased from $27.77B in FY2021 to $45.43B in FY2025, representing a 5-year revenue CAGR of 18.5%. Profit margins contracted over this period, with gross margin moving from 11.8% in FY2021 to 9.0% in FY2025, while operating margin fell from 3.7% to 1.7%. Net income declined from $1.18B in FY2024 to $472.0M in FY2025. In the trailing twelve months, revenue was $42.47B with diluted EPS of $0.09. For the latest quarter ended June 30, 2026, quarterly revenue fell 5.7% year-over-year and quarterly earnings dropped 75.3% year-over-year.

As of June 30, 2026, Molina Healthcare held $8.91B in cash and short-term investments compared to total debt of $3.95B, leaving net cash of $4.96B. Total assets stood at $16.00B and shareholders' equity was $4.17B, with a current ratio of 1.68 and a debt-to-equity ratio of 0.95. For FY2025, operating cash flow was -$535.0M and free cash flow was -$636.0M. Cash deployment during FY2025 included $101.0M in capital expenditures and $1.00B in share buybacks, with the 5-year share count changing by -12.6%.

Molina Healthcare trades at a market capitalization of $10.82B and an enterprise value of $5.02B. The forward P/E ratio is 18.9x, which is above the median of 17.3x for its US-listed Healthcare peers. Its enterprise value-to-ebitda multiple stands at 13.3x versus the peer median of 12.0x, while its price-to-sales multiple is 0.3x compared to 4.1x for the peer group. Over the past year, the stock gained 10.0%, trailing the S&P 500 (SPY) gain of 16.8%. Over a 5-year span, the stock declined 26.0% compared to an 83.0% rise for the S&P 500.

Wall Street analyst ratings include 3 Strong Buy, 1 Buy, 14 Hold, 1 Sell, and 0 Strong Sell recommendations. The mean price target is $209.12, reflecting a 0.8% premium to the last closing price of $207.36. For the fiscal year ending December 31, 2026, analysts estimate EPS of $5.25 and revenue of $44.46B. For the subsequent year, 6 analysts anticipate revenue of $48.04B and EPS of $8.55. The company beat EPS estimates in 2 of the last 4 quarters and is scheduled to report earnings next on October 21, 2026.

This page is an AI-written research summary of Molina Healthcare, Inc. (MOH). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: MOH income statement, MOH balance sheet, MOH key metrics, MOH analyst forecast, MOH chart. See the MOH stock overview for the latest quote and news.